MINNEAPOLIS, March 5, 2026 /PRNewswire/ — Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) ...

A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive ...

A large national study in Denmark following nearly 1,900 patients over almost a decade found that a minimally invasive ...

As expiration dates for key patents approach, the blockbuster cancer drug pembrolizumab (Keytruda) reigned as the biggest pharma moneymaker one more time, edging out the diabetes/weight-loss drug ...

A large national study in Denmark following nearly 1,900 patients over almost a decade found that a minimally invasive procedure ...

AngioDynamics ANGO recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical ...

Health care prices are on the rise, and patients are flummoxed that even insurance companies aren’t doing more to control costs.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

And it costs all of us ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, ...

Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has received Category III Current ...

The average age of men who get diagnosed is 67.